You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High risk PCI

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pressure-Volume Loop During High-Risk PCI

Recruiting
  • Coronary Artery Disease
  • High-risk percutaneous coronary intervention
  • Detroit, Michigan
    Henry Ford Hospital
Dec 6, 2022

High-risk Percutaneous Coronary Intervention, Heart Disease, Coronary Trial (VITALYST System)

Not yet recruiting
  • High-risk Percutaneous Coronary Intervention
  • Heart Disease, Coronary
  • VITALYST System
  • (no location specified)
Nov 9, 2023

High-risk PCI Trial in Padua (PCI procedure)

Not yet recruiting
  • High-risk PCI
  • PCI procedure
  • Padua, Italy
    Giuseppe Tarantini
Jul 15, 2022

High-Risk Percutaneous Coronary Intervention Trial in Tbilisi (The Elevate™ System)

Active, not recruiting
  • High-Risk Percutaneous Coronary Intervention
  • The Elevate™ System
  • Tbilisi, Georgia
    Israeli-Georgian Medical Research Clinic "Helsicore"
Oct 24, 2023

High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)

Not yet recruiting
  • High-risk Percutaneous Coronary Intervention
  • The Elevate™ System
  • New York, New York
    New York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023

Coronary Artery Disease Trial in Nijmegen (Extracorporeal Membrane Oxygenation)

Completed
  • Coronary Artery Disease
  • Extracorporeal Membrane Oxygenation
  • Nijmegen, Netherlands
    Radboud University Medical Centre
May 20, 2022

Patients Using Sodium Bicarbonate

Not yet recruiting
  • Cardiogenic Shock
  • High Risk PCI
  • Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solution
  • Impella RP with Sodium Bicarbonate used as purge solution
  • (no location specified)
Apr 20, 2023

Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)

Active, not recruiting
  • Coronary Microvascular Dysfunction
  • Beijing, Beijing, China
    Peking university first hospital
Aug 1, 2023

Mantle Cell Lymphoma Trial in Houston (Ibrutinib)

Recruiting
  • Mantle Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Nov 1, 2022

Chronic Lymphocytic Leukemia Trial in Houston (Ibrutinib, Venetoclax)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Coronary Artery Disease Trial

Not yet recruiting
  • Coronary Artery Disease
    • (no location specified)
    May 7, 2022

    Coronary Artery Disease With Myocardial Infarction Trial in Korea, Republic of (routine stress testing, No Routine stress

    Completed
    • Coronary Artery Disease With Myocardial Infarction
    • routine stress testing
    • No Routine stress testing
    • Chuncheon, Korea, Republic of
    • +10 more
    Apr 3, 2022

    IHD, LV Dysfunction Trial in Copenhagen (PCI, CABG)

    Not yet recruiting
    • IHD
    • LV Dysfunction
    • PCI
    • CABG
    • Copenhagen, Denmark
      Rigshospitalet, University of Copenhagen
    Sep 11, 2022

    ST Elevation Myocardial Infarction Trial in Germany (RIC + PostC + Standard PCI, Standard PCI)

    Recruiting
    • ST Elevation Myocardial Infarction
    • RIC + PostC + Standard PCI
    • Standard PCI
    • Bremen, Germany
    • +8 more
    Mar 24, 2022

    Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Completed
    • Loss of Chromosome 17p
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    Chronic Total Occlusion of Coronary Artery, Angina Pectoris, Quality of Life Trial in Bergen, Glasgow (Chronic total

    Recruiting
    • Chronic Total Occlusion of Coronary Artery
    • +3 more
    • Chronic total occlusion(CTO) percutaneous coronary intervention (PCI)
    • Bergen, Norway
    • +1 more
    Dec 8, 2021

    Cardiac Disease, PCI, High Bleeding Risk Trial in Netherlands (Supraflex Cruz 60 Micron, Ultimaster Tansei 80 Micron)

    Recruiting
    • Cardiac Disease
    • +2 more
    • Supraflex Cruz 60 Micron
    • Ultimaster Tansei 80 Micron
    • 's-Hertogenbosch, Netherlands
    • +10 more
    Sep 13, 2021

    Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

    Active, not recruiting
    • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
    • +2 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 20, 2023

    Coronary Stenosis Trial in Tel Aviv (Percutaneous Coronary Intervention (PCI))

    Completed
    • Coronary Stenosis
    • Percutaneous Coronary Intervention (PCI)
    • Tel Aviv, Israel
      Medinol LTD
    Aug 31, 2021

    Coronary Artery Disease, Unstable Angina, Angina, Stable Trial in United States (Prophylactic Impella support for a non-emergent

    Completed
    • Coronary Artery Disease
    • +3 more
    • Prophylactic Impella support for a non-emergent PCI
    • Phoenix, Arizona
    • +20 more
    Dec 10, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (biological, drug, other)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Identify Patients Undergoing Elective PCI at Risk of Peri-PCI

    Recruiting
    • Coronary Artery Disease
    • Assessment of platelet reactivity
    • Troponin measurement
    • Jacksonville, Florida
      University of Florida Jacksonville
    Nov 15, 2022

    Coronary Stenoses Trial in Korea, Republic of (Tailored antithrombotic strategy, Conventional antithrombotic strategy)

    Recruiting
    • Coronary Stenoses
    • Tailored antithrombotic strategy
    • Conventional antithrombotic strategy
    • Anyang, Korea, Republic of
    • +19 more
    Jul 19, 2021

    High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI) Trial in Ciudad de México (Drug

    Terminated
    • High Bleeding Risk
    • +2 more
    • Drug Eluting Balloon (DEB)
    • Drug Eluting Stents (DES)
    • Ciudad de México, Mexico
      Instituto Nacional de Cardiologia "Ignacio Chávez"
    Oct 19, 2021

    Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Refractory High Risk Myelodysplastic Syndrome Trial in

    Completed
    • Myelodysplastic Syndrome
    • +4 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 11, 2021